On January 21, Prof. Dr. Truong Quang Binh, Chairman of the Scientific Council, University of Medicine and Pharmacy Hospital, Ho Chi Minh City, announced the above information. Currently, the hospital has tested more than 120 cases of AI application in echocardiography, giving "very good diagnostic results but not taking much time".
According to statistics from the World Health Organization (WHO), cardiovascular disease continues to be the leading cause of death globally, accounting for about 17.9 million deaths each year. Of which, heart failure is still a major challenge for medicine, there is no weapon to completely solve the problem, and the fight against the disease is still passive.
Heart failure is a condition in which the heart muscle's ability to pump blood is reduced, leading to insufficient blood and oxygen supply for the body's needs. It leads to complications such as respiratory failure or damage to the liver and kidneys if not treated promptly. In addition, heart failure is a late-stage disease of cardiovascular or non-cardiovascular diseases. This is a dangerous disease with a re-hospitalization rate of up to 60% within 3 months after discharge as well as a very high mortality rate.
Diagnosing heart failure is difficult, especially with heart failure with preserved ejection fraction - a common syndrome in the elderly. Despite many abnormalities, the ejection fraction is still within normal limits, making disease detection time-consuming and easy to miss.
To solve this problem, Ho Chi Minh City University of Medicine and Pharmacy Hospital has researched and applied AI in echocardiography. The technology helps doctors perform ultrasound automatically, quickly, accurately and consistently, improving the effectiveness of diagnosis and treatment. AI is estimated to be able to detect an additional 20% of missed cases of heart failure with preserved ejection fraction, while shortening the diagnosis time from 35-40 minutes to 10 minutes, reducing the burden on medical staff and treatment costs.
The hospital leader added that in the future, after having research results on the effectiveness of AI applications in echocardiography, the facility will have reports to propose applying health insurance policies for this technique.
In the period of 2025-2027, Ho Chi Minh City University of Medicine and Pharmacy Hospital and the supplier Astra Zeneca will continue to promote clinical research programs, train medical staff in applying new technologies, and expand international cooperation in the field of digital transformation. This is the premise for building a modern medical ecosystem, ensuring that all patients have access to the most advanced medical solutions, contributing to improving the health care system.ác chăm sóc sức khỏe tại Việt Nam.
Source: https://vnexpress.net/benh-vien-viet-nam-dung-ai-sieu-am-tim-4841726.html
